Directory
>
Renu Vaish
Renu Vaish
Chief Regulatory Officer | Ambrx
Pennsylvania, United States
Renu Vaish
Summary
Renu Vaish is a seasoned Chief Regulatory Officer at Ambrx, with a robust background in regulatory affairs and drug development, particularly in oncology. With a career spanning over 15 years, she has held senior leadership roles in various prominent biopharmaceutical companies, showcasing her expertise in navigating complex regulatory landscapes. Renu is recognized for her strategic thinking and ability to implement innovative regulatory solutions that drive business success. Her experience includes leading teams through significant organizational changes and fostering growth in dynamic environments. Renu holds a Master's degree in Science and a Bachelor's in Cellular and Molecular Biology, reflecting her strong technical foundation. Her passion for advancing healthcare through regulatory excellence is evident in her commitment to improving patient outcomes. Renu's professional journey highlights her adaptability and leadership in a rapidly evolving industry, making her a thought leader in her field.
Renu Vaish
Work Experience
Chief Regulatory Officer at
Ambrx
July 2023 - Present
Senior Vice President, Regulatory Affairs at
SpringWorks Therapeutics
September 2021 - June 2023
Vice President, Worldwide Cell Therapy, Regulatory Affairs at
Kite Pharma
July 2020 - September 2021
Senior Vice President, Global Regulatory Affairs and Quality at
Atara Biotherapeutics
September 2018 - July 2020
Associate Vice President, Global Regulatory Affairs, Oncology at
Merck
March 2017 - September 2018
Executive Director, Oncology Regulatory Affairs, Merck at
Merck
July 2016 - March 2017
Vice President, Regulatory Affairs at
Edge Therapeutics, Inc.
January 2015 - July 2016
Executive Director, Global Regulatory Oncology Affairs at
Bristol Myers Squibb
September 2007 - January 2015
Renu Vaish
Education
Massachusetts College of Pharmacy and Health Sciences, Master Of Science (M.Sc.)
Concordia University, Bachelor Of Science - Bs
Frequently Asked Questions about Renu Vaish
What is Renu Vaish email address?
Renu Vaish's primary email address is **********@ambrx.com. To view the full verified email and additional contact details, sign up for free with Muraena.
What company does Renu Vaish work for?
Renu Vaish is a Chief Regulatory Officer at Ambrx, a company specializing in Commercial physical research.
Where Renu Vaish graduated from?
Renu Vaish holds a degree in from Massachusetts College of Pharmacy and Health Sciences.
How can I directly contact Renu Vaish?
To contact Renu Vaish directly, you can use the email address **********@ambrx.com. Complete contact information is available upon registration with Muraena.
Who is Renu Vaish?
Renu Vaish is a seasoned Chief Regulatory Officer at Ambrx, with a robust background in regulatory affairs and drug development, particularly in oncology. With a career spanning over 15 years, she has held senior leadership roles in various prominent biopharmaceutical companies, showcasing her expertise in navigating complex regulatory landscapes. Renu is recognized for her strategic thinking and ability to implement innovative regulatory solutions that drive business success. Her experience includes leading teams through significant organizational changes and fostering growth in dynamic environments. Renu holds a Master's degree in Science and a Bachelor's in Cellular and Molecular Biology, reflecting her strong technical foundation. Her passion for advancing healthcare through regulatory excellence is evident in her commitment to improving patient outcomes. Renu's professional journey highlights her adaptability and leadership in a rapidly evolving industry, making her a thought leader in her field.
Renu`s contact details
**********@ambrx.com
******@amgen.com
Colleagues
Chief Scientific Officer and GM China
Executive Director, Regulatory Affairs
President and Chief Executive Officer
Executive Vice President; Head of Clinical
Chief Financial Officer
Executive Vice President, Development Operations
Vice President, Pharmaceutical & Analytical Development at Ambrx, a Johnson & Johnson Co.
VP, Head of Medical Affairs